gadolinium dtpa has been researched along with thalidomide in 3 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (thalidomide) | Trials (thalidomide) | Recent Studies (post-2010) (thalidomide) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 9,789 | 1,385 | 4,342 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | thalidomide (IC50) |
|---|---|---|---|
| Cereblon isoform 4 | Magnetospirillum gryphiswaldense | 7.8 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.37 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 0.5 | |
| DNA damage-binding protein 1 | Homo sapiens (human) | 1.38 | |
| Protein cereblon | Homo sapiens (human) | 1.38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelbrecht, V; Gattermann, N; Germing, U; Haas, R; Mödder, U; Scherer, A; Strupp, C; Willers, R; Wittsack, HJ | 1 |
| Ansiaux, R; Baudelet, C; Beghein, N; De Wever, J; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Martinive, P; Sonveaux, P | 1 |
| Ch'ang, HJ; Chen, LT; Hsu, C; Liang, PC; Liu, TW; Shih, TT | 1 |
1 trial(s) available for gadolinium dtpa and thalidomide
| Article | Year |
|---|---|
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide.
Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Hepatocellular; Combined Modality Therapy; Contrast Media; Disease-Free Survival; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Signal Processing, Computer-Assisted; Survival Rate; Thalidomide; Treatment Outcome | 2015 |
2 other study(ies) available for gadolinium dtpa and thalidomide
| Article | Year |
|---|---|
[Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy].
Topics: Adult; Aged; Angiogenesis Inhibitors; Bone Marrow; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Neovascularization, Pathologic; Primary Myelofibrosis; Thalidomide; Treatment Outcome | 2002 |
Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment.
Topics: Angiogenesis Inhibitors; Animals; Contrast Media; Electron Spin Resonance Spectroscopy; Fibrosarcoma; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C3H; Osmotic Pressure; Oxygen; Oxygen Consumption; Radiation Tolerance; Thalidomide; X-Rays | 2005 |